CTSO
Cytosorbents Corp
$0.37
-0.02 (-5.12%)
At close · Jul 16
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These cash and restricted cash balances considered with our historical and expected future cash used in operations, notwithstanding our Strategic Workforce and Cost Reduction Plan and the impact of the Amended Loan and Security Agreement, raises substantial doubt about the Company's ability to continue as a going concern within twelve months after the date that the accompanying condensed consolidated financial statements are issued.”View the 10-Q filed May 13, 2026
Market Cap
$22.61M
Shares
62,794,748
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$37.06M
+4.1%
FY2025
Net Income
-$8.2M
+60.4%
FY2025
Gross Margin
71.48%
+1.6pp
FY2025
Operating Margin
-39.79%
+6.4pp
FY2025
Diluted EPS
-$0.13
+65.8%
FY2025
Operating Cash Flow
-$12.38M
+14.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 | FY2002 | FY2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $37.2M | $37.06M | $35.6M | $31.08M | $34.69M | $43.17M | $41M | $24.95M | $22.5M | $15.15M | $9.53M | $4.79M | $4.12M | $2.42M | $1.34M | $36.08K | — | — | — | — | — | — | — | — | — | — | |
| $10.79M | $10.57M | $10.71M | $9.13M | $13.96M | $11.05M | $11.05M | $7.36M | $7.49M | $5.52M | $3.95M | $2.21M | $2.13M | $1.91M | $319.3K | $11.76K | — | — | — | — | — | — | — | — | — | — | |
| $26.41M | $26.49M | $24.89M | $21.95M | $20.73M | $32.12M | $29.95M | $17.59M | $15.01M | $9.63M | $5.57M | $2.58M | $1.99M | $511.1K | $1.02M | $24.32K | — | — | — | — | — | — | — | — | — | — | |
| — | 71.48% | 69.92% | 70.62% | 59.77% | 74.41% | 73.05% | 70.48% | 66.72% | 63.58% | 58.5% | 53.82% | 48.24% | 21.1% | 76.22% | 67.4% | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | $15.73M | $15.12M | $16.38M | $8.81M | $12.09M | $7.72M | $3.22M | $4.07M | $3.87M | $2.43M | $1.74M | $2.53M | $2.89M | $1.76M | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $25.06M | $759.39K | — | — | — | — | — | — | — | — | — | |
| $35.36M | $35.65M | $33.73M | $38.31M | $34.29M | $35.75M | $28.46M | $22.01M | $20.87M | $14.91M | $11.81M | $6.92M | $5.55M | $2.58M | $1.35M | $1.23M | — | — | — | — | — | — | — | — | — | — | |
| — | $262K | $235K | — | — | — | — | — | — | — | — | — | — | — | $183.56K | $183.56K | — | — | — | — | — | — | — | — | — | — | |
| — | $1.23M | $1.34M | $1.46M | $882.62K | $731.58K | $660.79K | $581.53K | $390.55K | $218.27K | $161.61K | $112.97K | $65.55K | $64.35K | $54.61K | $39.15K | $17.8K | — | — | — | — | — | — | — | — | — | |
| — | $510K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $40.32M | $41.24M | $41.34M | $53.9M | $52.25M | $54.86M | $40.32M | $36.56M | $30.6M | $19.47M | $17.07M | $11.88M | $8.88M | $5.22M | $4.51M | $4.46M | $2.82M | — | — | — | — | — | — | — | — | — | |
| -$13.91M | -$14.75M | -$16.45M | -$31.95M | -$31.52M | -$22.74M | -$10.37M | -$18.97M | -$15.58M | -$9.84M | -$11.49M | -$9.3M | -$6.89M | -$4.71M | -$3.49M | -$4.44M | -$2.82M | — | — | — | — | — | — | — | — | — | |
| — | -39.79% | -46.22% | -102.78% | -90.87% | -52.69% | -25.29% | -76.05% | -69.25% | -64.96% | -120.62% | -194.17% | -167.19% | -194.55% | -259.94% | -12297.71% | — | — | — | — | — | — | — | — | — | — | |
| — | -$13.52M | -$15.12M | -$30.49M | -$30.64M | -$22.01M | -$9.71M | -$18.39M | -$15.19M | -$9.62M | -$11.33M | -$9.19M | -$6.83M | -$4.65M | -$3.44M | -$4.4M | -$2.81M | — | — | — | — | — | — | — | — | — | |
| $1.66M | $6.15M | -$5.96M | $1.89M | -$2.38M | -$2.55M | $1.41M | -$1.38M | -$2.25M | $705.06K | -$589.88K | -$497.98K | -$2.81M | -$422.84K | -$564.43K | -$1.04M | -$84.85K | — | — | — | — | — | — | — | — | — | |
| — | -$8.6M | -$22.41M | -$30.06M | -$33.91M | -$25.29M | -$8.96M | -$20.36M | -$17.83M | -$9.14M | -$12.08M | -$9.8M | -$9.71M | -$5.14M | -$4.06M | -$5.48M | -$2.91M | — | — | — | — | — | — | — | — | — | |
| — | -$401K | -$1.69M | -$813.74K | -$1.09M | -$736K | -$1.13M | -$1.09M | -$619.55K | -$676.74K | -$318.55K | -$324.61K | -$385.64K | -$458.28K | -$391.76K | -$547.32K | — | — | — | — | — | — | — | — | — | — | |
| -$11.85M | -$8.2M | -$20.72M | -$29.25M | -$32.81M | -$24.56M | -$7.84M | -$19.27M | -$17.21M | -$8.46M | -$11.76M | -$9.48M | -$9.32M | -$4.68M | -$3.66M | -$5.48M | -$2.91M | -$2.74M | -$3.02M | -$3.35M | -$76.72M | -$3.67M | -$1.1M | -$6.01M | -$11.87M | -$15.39M | |
| — | -22.12% | -58.21% | -94.09% | -94.59% | -56.89% | -19.11% | -77.22% | -76.48% | -55.84% | -123.46% | -197.78% | -226.1% | -193.08% | -272.8% | -15193.88% | — | — | — | — | — | — | — | — | — | — | |
| -$11.85M | -$8.2M | -$20.72M | -$29.25M | -$32.81M | -$24.56M | -$7.84M | -$19.27M | -$17.21M | -$8.8M | -$11.76M | -$9.48M | -$18.59M | -$7.07M | -$6.17M | -$8.57M | -$5.09M | — | — | — | — | — | — | — | — | — | |
| -$15.47M | -$15.43M | -$17M | -$31.05M | -$31.01M | -$22.3M | -$10.1M | -$19.03M | -$16.56M | -$9.72M | -$11.45M | -$9.12M | -$9.04M | -$4.72M | -$3.68M | -$5.48M | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$0.13 | -$0.38 | -$0.65 | -$0.75 | -$0.57 | -$0.20 | -$0.60 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$0.13 | -$0.38 | -$0.65 | -$0.75 | -$0.57 | -$0.20 | -$0.60 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 62.23M | 54.43M | 44.66M | 43.57M | 43.36M | 38.82M | 32.26M | 30.72M | 27.61M | 25.43M | 24.89M | 14.38M | 9.44M | 198.23M | 160.24M | — | — | — | — | — | — | — | — | — | — |
| shares | — | 62.23M | 54.43M | 44.66M | 43.57M | 43.36M | 38.82M | 32.26M | 30.72M | 27.61M | 25.43M | 24.89M | 14.38M | 9.44M | 198.23M | 160.24M | — | — | — | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Showing the latest 26 of 28 periods — chart a line item for full history.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.93×
Medical Devices median 2.33×
EV/EBIT
—
Medical Devices median 21.62×
P/E (TTM)
—
Medical Devices median 28.40×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Single Reportable Segment | $37,063,000 | $35,595,000 | $31,084,953 |
By Product & Service (USD)
| Component | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|
| Product | $31,084,953 | $29,359,910 | $40,108,567 | $39,452,502 | $22,765,854 | $20,252,383 |
| CytoSorb Sales | $31,015,268 | $28,572,709 | $39,996,700 | $39,342,102 | $22,545,754 | $20,143,354 |
| Grant | $5,264,426 | $5,328,899 | $3,056,960 | $1,552,099 | $2,183,619 | $2,251,525 |
| Other Sales | $69,685 | $787,201 | $111,867 | $110,400 | $220,100 | $109,029 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Single Reportable Segment | -$14,749,000 | -$16,452,000 |
Operating Margin by Segment (%)
| Component | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Single Reportable Segment | -39.8% | -46.2% |